October 20, 2015 — Results from the BRAVO 3 trial found that bivalirudin did not significantly reduce major bleeding ...
Structural Heart
This structural heart channel includes news, videos, podcasts and other content related to diagnosis and treatment of structural heart disease. Topics covered include heart valve repair and replacement, transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR), transcatheter tricuspid valve replacement (TTVR), left atrial appendage (LAA) occlusion, heart failure interventional device therapies, and closing holes in the heart using, including occlusion of atrial septal defects (ASDs), ventricular septal defects (VSDs) and patent foramen ovales (PFOs).
There were several overarching technology trends seen at the 2015 Transcatheter Cardiovascular Therapeutics (TCT) annual ...
October 16, 2015 — Long-term study results from the RESPECT trial found that closing a patent foramen ovale (PFO) with ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
October 14, 2015 — Claret Medical, an innovator in cardiovascular cerebral protection, Data presented this week at ...
October 15, 2015 — Edwards Lifesciences Corp. announced that details on the 13 first-in-human compassionate use cases wi ...
October 15, 2015 — One-year patient outcomes from the PARTNER II trial showed the low rate of 30-day complications with ...
October 15, 2015 — U.S. Food and Drug Administration (FDA) has cleared Edwards Lifesciences Sapien XT transcatheter ...
October 14, 2015 — Boston Scientific Corp. announced it has closed on an additional round of financing with MValve ...
September 18, 2015 — St. Jude Medical Inc. announced European CE Mark approval for the 27mm and 29mm Portico transcathet ...
September 15, 2015 — coramaze technologies GmbH, a German medical device company, announced the closing of a EUR 4.5 ...
September 14, 2015 — Startup cardiovascular device manufacturer Valtech Cardio Ltd. announced it has received CE Marking ...
September 10, 2015 — Sunshine Heart Inc. announced commencement of a new study examining the impact of the C-Pulse ...
September 10, 2015 — The Carillon mitral contour system is projected to be a cost-effective treatment option when ...
September 8, 2015 — Sunshine Heart Inc. announced the U.S. Food and Drug Administration (FDA) has approved an amendment ...
September 4, 2015 — Gene transfer therapy to correct an enzyme abnormality involved in myocardial contraction and ...